Journal article
Angiotensin-converting enzyme 2 (ACE2) activator DIZE ameliorates endotoxin-induced uveitis in mice
Y Qiu, PK Shil, P Zhu, H Yang, A Verma, B Lei, Q Li
Investigative Ophthalmology and Visual Science | ASSOC RESEARCH VISION OPHTHALMOLOGY INC | Published : 2014
Abstract
Purpose. Uveitis is a common cause of vision loss. The renin angiotensin system (RAS), which plays a vital role in cardiovascular system, is a potent mediator of inflammation and has been implicated in the pathogenesis of uveitis. A newly identified axis of RAS, ACE2/Ang-(1-7)/Mas, has emerged as a novel target because it counteracts the deleterious effect of angiotensin II. The purpose of this study was to investigate the effect of endogenous ACE2 activation in preventing endotoxin-induced uveitis (EIU) in mice. Methods. ACE2 activator diminazene aceturate (DIZE) was administered both systemically and locally. For systemic administration, female BALB/c mice received intraperitoneal injectio..
View full abstractGrants
Awarded by National Eye Institute
Funding Acknowledgements
Supported by American Diabetes Association, American Heart Association, Research to Prevent Blindness, National Institutes of Health Grants EY021752 and EY021721, and National Natural Science Foundation of China (81271033). The authors alone are responsible for the content and writing of the paper.